DK0840621T3 - - Google Patents
Info
- Publication number
- DK0840621T3 DK0840621T3 DK96928368T DK96928368T DK0840621T3 DK 0840621 T3 DK0840621 T3 DK 0840621T3 DK 96928368 T DK96928368 T DK 96928368T DK 96928368 T DK96928368 T DK 96928368T DK 0840621 T3 DK0840621 T3 DK 0840621T3
- Authority
- DK
- Denmark
- Prior art keywords
- gestagen
- oestrogen
- ethoxyethoxy
- tts
- androgen
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
- A61K9/7061—Polyacrylates
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19526864A DE19526864A1 (de) | 1995-07-22 | 1995-07-22 | Hormonpflaster |
PCT/EP1996/003229 WO1997003698A1 (de) | 1995-07-22 | 1996-07-22 | Hormonpflaster |
Publications (1)
Publication Number | Publication Date |
---|---|
DK0840621T3 true DK0840621T3 (da) | 2002-04-15 |
Family
ID=7767564
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK96928368T DK0840621T3 (da) | 1995-07-22 | 1996-07-22 |
Country Status (21)
Country | Link |
---|---|
US (1) | US5985311A (da) |
EP (1) | EP0840621B1 (da) |
JP (1) | JPH11504038A (da) |
KR (1) | KR19990035795A (da) |
CN (1) | CN1195994A (da) |
AT (1) | ATE212234T1 (da) |
AU (1) | AU6786696A (da) |
BR (1) | BR9609794A (da) |
CA (1) | CA2227538A1 (da) |
CZ (1) | CZ20498A3 (da) |
DE (3) | DE19526864A1 (da) |
DK (1) | DK0840621T3 (da) |
ES (1) | ES2171710T3 (da) |
HU (1) | HUP9900301A3 (da) |
MX (1) | MX9800469A (da) |
NO (1) | NO980277D0 (da) |
NZ (1) | NZ316026A (da) |
PL (1) | PL324552A1 (da) |
PT (1) | PT840621E (da) |
SK (1) | SK8198A3 (da) |
WO (1) | WO1997003698A1 (da) |
Families Citing this family (59)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050276836A1 (en) * | 1997-06-11 | 2005-12-15 | Michelle Wilson | Coated vaginal devices for vaginal delivery of therapeutically effective and/or health-promoting agents |
DE19728516C2 (de) * | 1997-07-04 | 1999-11-11 | Sanol Arznei Schwarz Gmbh | TTS zur Verabreichung von Levonorgestrel und gegebenenfalls Estradiol |
FR2779062A1 (fr) * | 1998-06-02 | 1999-12-03 | Investigations Therapeutiques | Preparation sous forme galenique simple visant a limiter les effets induits durant la menopause et posterieurement et traitement avec cette preparation |
DE19901085C2 (de) * | 1999-01-14 | 2003-12-18 | Lohmann Therapie Syst Lts | Transdermales therapeutisches System mit einer selbstklebenden Matrix, enthaltend organische Säure-Additionssalze von Alkaloiden des Morphin- bzw. Morphinantyps |
USRE44145E1 (en) | 2000-07-07 | 2013-04-09 | A.V. Topchiev Institute Of Petrochemical Synthesis | Preparation of hydrophilic pressure sensitive adhesives having optimized adhesive properties |
EP1216699A1 (de) * | 2000-12-21 | 2002-06-26 | Schering Aktiengesellschaft | Transdermalsystem enthaltend ein hochpotentes Gestagen |
US8728445B2 (en) | 2001-05-01 | 2014-05-20 | A.V. Topchiev Institute Of Petrochemical Synthesis, Russian Academy Of Sciences | Hydrogel Compositions |
DE60239528D1 (de) | 2001-05-01 | 2011-05-05 | Corium International Redwood City | Zweiphasige, wasserabsorbierende bioadhäsive zusammenstezung |
US20050113510A1 (en) | 2001-05-01 | 2005-05-26 | Feldstein Mikhail M. | Method of preparing polymeric adhesive compositions utilizing the mechanism of interaction between the polymer components |
US8206738B2 (en) | 2001-05-01 | 2012-06-26 | Corium International, Inc. | Hydrogel compositions with an erodible backing member |
US20050215727A1 (en) | 2001-05-01 | 2005-09-29 | Corium | Water-absorbent adhesive compositions and associated methods of manufacture and use |
US8541021B2 (en) | 2001-05-01 | 2013-09-24 | A.V. Topchiev Institute Of Petrochemical Synthesis | Hydrogel compositions demonstrating phase separation on contact with aqueous media |
US8840918B2 (en) | 2001-05-01 | 2014-09-23 | A. V. Topchiev Institute of Petrochemical Synthesis, Russian Academy of Sciences | Hydrogel compositions for tooth whitening |
KR20030028253A (ko) * | 2001-09-27 | 2003-04-08 | (주)지씨아이 | 잔탄검과 알긴을 이용한 항고지단백혈증 경피투과제제의제조 |
JP5027373B2 (ja) * | 2002-08-09 | 2012-09-19 | 帝國製薬株式会社 | エストラジオール含有貼付剤 |
JP4919573B2 (ja) * | 2002-08-09 | 2012-04-18 | 帝國製薬株式会社 | ノルエチステロン含有外用貼付剤 |
US8124122B2 (en) | 2002-08-09 | 2012-02-28 | Teikoku Seiyaku Co., Ltd. | Female hormone-containing patch |
KR20040037653A (ko) * | 2002-10-29 | 2004-05-07 | 대한민국(경북대학교 총장) | 갈변 방지제 |
JO2492B1 (en) | 2003-04-28 | 2009-10-05 | شيرينج ايه جي | A pharmaceutical formula in the form of aqueous gel for the skin use of its active ingredients |
CN1929819B (zh) | 2004-01-30 | 2012-02-29 | 考里安国际公司 | 递送活性剂的快速溶解膜 |
RU2393877C2 (ru) | 2004-08-05 | 2010-07-10 | Кориум Интернэшнл, Инк. | Адгезивная композиция |
WO2006036899A2 (en) * | 2004-09-27 | 2006-04-06 | Corium International, Inc. | Transdermal systems for the delivery of estrogens and progestins |
US20080089925A1 (en) * | 2004-11-10 | 2008-04-17 | Masato Wakamatsu | Drug for External Use and Adhesive Patch |
ES2389630T3 (es) * | 2004-11-10 | 2012-10-29 | Hisamitsu Pharmaceutical Co., Inc. | Fármacos para uso externo y parche adhesivo |
ATE509969T1 (de) * | 2005-09-23 | 2011-06-15 | Nat Starch Chem Invest | Klebstoffe auf acrylpolymerbasis |
US20070141132A1 (en) * | 2005-11-02 | 2007-06-21 | Hagit Sacks | Human growth hormone patch formulations |
WO2008091588A1 (en) | 2007-01-22 | 2008-07-31 | Targacept, Inc. | Intranasal, buccal, and sublingual administration of metanicotine analogs |
EP2187969A2 (en) * | 2007-08-17 | 2010-05-26 | Arcion Therapeutics, Inc. | High concentration local anesthetic formulations |
WO2010019953A1 (en) | 2008-08-15 | 2010-02-18 | Arcion Therapeutics, Inc. | High concentration local anesthetic formulations for treating non-neuropathic pain |
DE102008059054A1 (de) | 2008-11-26 | 2010-05-27 | Otto Bock Pur Life Science Gmbh | Polyurethanpflaster für die transdermale Applikation von Wirkstoffen und Verfahren zu dessen Herstellung |
US8784879B2 (en) | 2009-01-14 | 2014-07-22 | Corium International, Inc. | Transdermal administration of tamsulosin |
US9301920B2 (en) | 2012-06-18 | 2016-04-05 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
PL2782584T3 (pl) | 2011-11-23 | 2021-12-13 | Therapeuticsmd, Inc. | Naturalne skojarzone hormonalne formulacje i terapie zastępcze |
US20130338122A1 (en) | 2012-06-18 | 2013-12-19 | Therapeuticsmd, Inc. | Transdermal hormone replacement therapies |
US20150196640A1 (en) | 2012-06-18 | 2015-07-16 | Therapeuticsmd, Inc. | Progesterone formulations having a desirable pk profile |
US10806740B2 (en) | 2012-06-18 | 2020-10-20 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
US10806697B2 (en) | 2012-12-21 | 2020-10-20 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US9180091B2 (en) | 2012-12-21 | 2015-11-10 | Therapeuticsmd, Inc. | Soluble estradiol capsule for vaginal insertion |
US11266661B2 (en) | 2012-12-21 | 2022-03-08 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US10471072B2 (en) | 2012-12-21 | 2019-11-12 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US10537581B2 (en) | 2012-12-21 | 2020-01-21 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US10568891B2 (en) | 2012-12-21 | 2020-02-25 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US11246875B2 (en) | 2012-12-21 | 2022-02-15 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US10206932B2 (en) | 2014-05-22 | 2019-02-19 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
PL3372229T3 (pl) | 2014-06-06 | 2021-10-04 | Ovid Therapeutics, Inc. | Sposoby zwiększenia hamowania tonicznego i leczenia zespołu angelmana |
WO2016018993A1 (en) | 2014-07-29 | 2016-02-04 | Therapeuticsmd, Inc. | Transdermal cream |
JP2018520189A (ja) | 2015-07-17 | 2018-07-26 | オービッド・セラピューティクス・インコーポレイテッドOvid Therapeutics, Inc. | ガボキサドールでの発達障害の処置方法 |
US9682069B2 (en) | 2015-07-17 | 2017-06-20 | Ovid Therapeutics Inc | Methods of treating Dravet syndrome |
US10328087B2 (en) | 2015-07-23 | 2019-06-25 | Therapeuticsmd, Inc. | Formulations for solubilizing hormones |
AU2017239645A1 (en) | 2016-04-01 | 2018-10-18 | Therapeuticsmd, Inc. | Steroid hormone pharmaceutical composition |
WO2017173044A1 (en) | 2016-04-01 | 2017-10-05 | Therapeuticsmd Inc. | Steroid hormone compositions in medium chain oils |
US10660967B2 (en) | 2016-10-21 | 2020-05-26 | Augusta University Research Institute, Inc. | Curcumin conjugates and methods of use thereof |
US10071083B2 (en) | 2017-02-03 | 2018-09-11 | Ovid Therapeutics Inc | Use of gaboxadol in the treatment of tinnitus |
US10953036B2 (en) | 2017-11-20 | 2021-03-23 | University Of Georgia Research Foundation, Inc. | Compositions and methods of modulating HIF-2A to improve muscle generation and repair |
WO2019152808A1 (en) | 2018-02-01 | 2019-08-08 | Yale University | Compositions and methods for inhibition of nuclear-penetrating antibodies |
WO2021077070A1 (en) | 2019-10-18 | 2021-04-22 | Yale University | Compositions and methods for inhibition of cell-penetrating antibodies |
US11633405B2 (en) | 2020-02-07 | 2023-04-25 | Therapeuticsmd, Inc. | Steroid hormone pharmaceutical formulations |
US11850220B2 (en) | 2020-05-19 | 2023-12-26 | Augusta University Research Institute, Inc. | Synthesis of ibuprofen hybrid conjugates as anti-inflammatory and analgesic agents |
US11858908B2 (en) | 2021-01-19 | 2024-01-02 | Augusta University Research Institute, Inc. | Compositions and methods for inhibiting IDO1 |
Family Cites Families (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5296230A (en) * | 1985-02-25 | 1994-03-22 | Rutgers, The State University Of New Jersey | Transdermal fertility control system and process |
CH674618A5 (da) * | 1987-04-02 | 1990-06-29 | Ciba Geigy Ag | |
US5223261A (en) * | 1988-02-26 | 1993-06-29 | Riker Laboratories, Inc. | Transdermal estradiol delivery system |
DE3910578A1 (de) * | 1989-03-29 | 1990-10-04 | Schering Ag | Mittel zur transdermalen applikation enthaltend gestoden |
US5057734A (en) * | 1988-11-30 | 1991-10-15 | Toyota Jidosha Kabushiki Kaisha | Apparatus for driving piezoelectric element for closing and opening valve member |
IL92496A0 (en) * | 1988-12-01 | 1990-08-31 | Schering Corp | Compositions for transdermal delivery of estradiol |
US5053227A (en) * | 1989-03-22 | 1991-10-01 | Cygnus Therapeutic Systems | Skin permeation enhancer compositions, and methods and transdermal systems associated therewith |
ATE107517T1 (de) * | 1989-05-25 | 1994-07-15 | Takeda Chemical Industries Ltd | Transdermales therapeutisches mittel. |
JP2718433B2 (ja) * | 1989-09-08 | 1998-02-25 | シグナス インコーポレイテッド | 経皮ドラッグデリバリーのための固体マトリックスシステム |
DE3933460A1 (de) * | 1989-10-06 | 1991-04-18 | Lohmann Therapie Syst Lts | Oestrogenhaltiges wirkstoffpflaster |
DE3942232A1 (de) * | 1989-12-21 | 1991-06-27 | Beiersdorf Ag | Schmelzhaftkleber auf acrylatbasis |
DE4020144A1 (de) * | 1990-06-25 | 1992-01-09 | Lohmann Therapie Syst Lts | Pflaster mit hohem gehalt an weichmachenden inhaltsstoffen |
DE4210165A1 (de) * | 1991-07-30 | 1993-02-04 | Schering Ag | Transdermale therapeutische systeme |
US5518734A (en) * | 1991-09-25 | 1996-05-21 | Beta Pharmaceuticals Co. | Transdermal delivery system for estradiol and process for manufacturing said device |
DE4210711A1 (de) * | 1991-10-31 | 1993-05-06 | Schering Ag Berlin Und Bergkamen, 1000 Berlin, De | Transdermale therapeutische systeme mit kristallisationsinhibitoren |
US5676968A (en) * | 1991-10-31 | 1997-10-14 | Schering Aktiengesellschaft | Transdermal therapeutic systems with crystallization inhibitors |
IT1253265B (it) * | 1991-11-25 | 1995-07-14 | Rotta Research Lab | Preparato a matrice copolimerica adesiva a base acrilica per il rilascio transdermico dell'estradiolo. |
US5314685A (en) * | 1992-05-11 | 1994-05-24 | Agouron Pharmaceuticals, Inc. | Anhydrous formulations for administering lipophilic agents |
GB2273044B (en) * | 1992-12-02 | 1997-04-09 | Pacific Chem Co Ltd | Medicinal patches for percutaneous administration |
DE4240806A1 (de) * | 1992-12-01 | 1994-06-09 | Schering Ag | Mittel zur transdermalen Applikation enthaltend 14alpha,17alpha-Ethanoestra-1,3,5(10)-trien-3,17beta-diol |
AU5718494A (en) * | 1992-12-31 | 1994-08-15 | Sunkyong Industries Co., Ltd. | Enhanced pharmaceutical compositions for skin penetration |
DE4309830C1 (de) * | 1993-03-26 | 1994-05-05 | Lohmann Therapie Syst Lts | Wirkstoffpflaster für die Abgabe von Estradiol an die Haut |
US5385736A (en) * | 1993-07-12 | 1995-01-31 | Minnesota Mining And Manufacturing Company | Transdermal melatonin delivery system |
WO1995005137A1 (en) * | 1993-08-16 | 1995-02-23 | Cygnus Therapeutic Systems | Transdermal delivery system using a combination of permeation enhancers |
DE4333595A1 (de) * | 1993-10-01 | 1995-04-06 | Labtec Gmbh | Transdermales therapeutisches System zur Applikation von Arzneimitteln auf die Haut |
JPH09510697A (ja) * | 1994-01-27 | 1997-10-28 | シエーリング アクチエンゲゼルシヤフト | 14α,17α−エタノエストラ−1,3,5(10)−トリエン−3,17β−ジオールを含有する経皮投与のための薬剤 |
DK0781122T3 (da) * | 1994-09-14 | 2000-10-30 | Minnesota Mining & Mfg | Matrix til transdermal lægmiddelafgivelse |
WO1996008255A1 (en) * | 1994-09-14 | 1996-03-21 | Minnesota Mining And Manufacturing Company | Transdermal device for delivery of levonorgestrel |
-
1995
- 1995-07-22 DE DE19526864A patent/DE19526864A1/de not_active Withdrawn
-
1996
- 1996-07-22 DK DK96928368T patent/DK0840621T3/da active
- 1996-07-22 HU HU9900301A patent/HUP9900301A3/hu unknown
- 1996-07-22 CN CN96196894A patent/CN1195994A/zh active Pending
- 1996-07-22 EP EP96928368A patent/EP0840621B1/de not_active Expired - Lifetime
- 1996-07-22 PL PL96324552A patent/PL324552A1/xx unknown
- 1996-07-22 AT AT96928368T patent/ATE212234T1/de not_active IP Right Cessation
- 1996-07-22 DE DE19680582T patent/DE19680582D2/de not_active Expired - Fee Related
- 1996-07-22 CA CA002227538A patent/CA2227538A1/en not_active Abandoned
- 1996-07-22 PT PT96928368T patent/PT840621E/pt unknown
- 1996-07-22 KR KR1019980700454A patent/KR19990035795A/ko not_active Application Discontinuation
- 1996-07-22 AU AU67866/96A patent/AU6786696A/en not_active Abandoned
- 1996-07-22 JP JP9506320A patent/JPH11504038A/ja not_active Ceased
- 1996-07-22 ES ES96928368T patent/ES2171710T3/es not_active Expired - Lifetime
- 1996-07-22 BR BR9609794A patent/BR9609794A/pt active Search and Examination
- 1996-07-22 DE DE59608650T patent/DE59608650D1/de not_active Expired - Fee Related
- 1996-07-22 CZ CZ98204A patent/CZ20498A3/cs unknown
- 1996-07-22 WO PCT/EP1996/003229 patent/WO1997003698A1/de not_active Application Discontinuation
- 1996-07-22 NZ NZ316026A patent/NZ316026A/xx unknown
- 1996-07-22 SK SK81-98A patent/SK8198A3/sk unknown
-
1998
- 1998-01-15 MX MX9800469A patent/MX9800469A/es not_active IP Right Cessation
- 1998-01-21 NO NO980277A patent/NO980277D0/no unknown
- 1998-01-22 US US09/010,534 patent/US5985311A/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
ATE212234T1 (de) | 2002-02-15 |
NO980277L (no) | 1998-01-21 |
AU6786696A (en) | 1997-02-18 |
EP0840621B1 (de) | 2002-01-23 |
PL324552A1 (en) | 1998-06-08 |
KR19990035795A (ko) | 1999-05-25 |
CA2227538A1 (en) | 1997-02-06 |
NO980277D0 (no) | 1998-01-21 |
SK8198A3 (en) | 1998-06-03 |
DE19526864A1 (de) | 1997-01-23 |
DE19680582D2 (de) | 1998-10-29 |
NZ316026A (en) | 1999-08-30 |
HUP9900301A2 (hu) | 1999-06-28 |
DE59608650D1 (de) | 2002-03-14 |
ES2171710T3 (es) | 2002-09-16 |
CN1195994A (zh) | 1998-10-14 |
HUP9900301A3 (en) | 1999-11-29 |
CZ20498A3 (cs) | 1998-06-17 |
PT840621E (pt) | 2002-06-28 |
EP0840621A1 (de) | 1998-05-13 |
MX9800469A (es) | 1998-09-30 |
US5985311A (en) | 1999-11-16 |
JPH11504038A (ja) | 1999-04-06 |
WO1997003698A1 (de) | 1997-02-06 |
BR9609794A (pt) | 1999-03-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK0840621T3 (da) | ||
ZA9610729B (en) | Transdermal device for the delivery of flurbiprofen. | |
AU3593597A (en) | Medical adhesive bandage, delivery system and method | |
ATE304845T1 (de) | Hautpflaster enthaltend testosteron und gegebenenfalls estrogen | |
AU4757496A (en) | Biodegradable implant for fracture nonunions | |
EP0624635A3 (en) | Pressure sensitive adhesives for medical use and medical band formed therefrom. | |
AU5740496A (en) | Micromechanical device and method for enhancing delivery of compounds through the skin | |
ES2147858T3 (es) | Matriz para el suministro transdermico de farmacos. | |
MX9802360A (es) | Adhesivo fundido en caliente sensible a la presion para etiquetas y cintas adhesivas. | |
DE59807891D1 (de) | Transdermales therapeutisches system (tts) enthaltend ammoniogruppenhaltige (meth)acrylatpolymere zur verabreichung von levonorgestrel | |
AU1429697A (en) | Systems and methods for the transdermal administration of androgenic agents | |
NZ308516A (en) | Transdermal therapeutic system (tts) for administering testosterone | |
CA2331414A1 (en) | Transdermal therapeutic system for the administration of candesartan | |
AU7172794A (en) | Transdermal delivery system package | |
ZA200107523B (en) | Method for improving the stability of stored and/or light-sensitive therapeutic systems or component thereof. | |
AU6614096A (en) | Agent, for transdermal application, containing esters of 3-ketodesogestrel | |
CA2305432A1 (en) | Method for preventing the misuse of a transdermal therapeutic system | |
AU3723695A (en) | Transdermal device for delivery of levonorgestrel | |
ZA966083B (en) | Agent for transdermal administration containing esters of 13-ethyl-17ß-hydroxy-11-methylene-18,19-dinor-17Ó-pregn-4-en-20-yn-3-one. | |
AU4015097A (en) | Transdermal therapeutic system having an active compound combination comprising oestriol | |
AU9359898A (en) | Use of moxonidine for the treatment of depression | |
AU8524098A (en) | System for generating instructions for speech application |